Effect of Cervical Block on Recurrent Laryngeal Nerve Monitoring During Thyroid Surgery
THYRODOUL2
Effect of Ultrasound-guided Intermediate Cervical Block on Recurrent Laryngeal Nerve Monitoring During Thyroid Surgery : a Randomised Non-inferiority Study
1 other identifier
interventional
120
1 country
1
Brief Summary
Non-inferiority study aimed to assess the impact of cervical block on recurrent laryngeal nerve monitoring during thyroid surgery Secondary outcomes will assess post-operative recovery, post-operative pain and post-operative dysphonia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 28, 2019
CompletedFirst Submitted
Initial submission to the registry
October 2, 2020
CompletedFirst Posted
Study publicly available on registry
October 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedOctober 14, 2020
October 1, 2020
1.9 years
October 2, 2020
October 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect on recurrent laryngeal nerve monitoring
Percentage of bilateral and unilateral non-response to recurrent laryngeal nerve monitoring
Before surgical dissection
Secondary Outcomes (5)
Postoperative recovery
7 days post surgery
Postoperative pain
First 24 hours post surgery
Early postoperative complications
First 24 hours post surgery
Postoperative dysphonia
During the first 24 hours and 7 days post surgery
Late postoperative complications
1 to 3 months post surgery
Study Arms (2)
General anesthesia without intermediate cervical block
NO INTERVENTIONGeneral anesthesia performed by the anesthesiologist
General anesthesia with intermediate cervical block
ACTIVE COMPARATORGeneral anesthesia performed by the anesthesiologist associated with an echoguided intermediate cervical block (bilateral in total thyroidectomy, unilateral in partial thyroidectomy) : 10 to 30cc of ropivacaine (2 to 3,75 %)
Interventions
Local anesthesia performed in addition to the general anesthesia
Eligibility Criteria
You may qualify if:
- Patients over 18, able to give consent after clear and fair information
- Affiliated to social security
- Total thyroidectomy performed in the context of Graves' disease in biological euthyroidism with the need for surgical treatment (pregnancy project, fluctuating TSH, etc.), or multiheteronodular goiter with suspect or compressive nodules, or lobo-isthmectomy
- No previous homolateral cervical surgery
- Professional activity
- Telephone line (at home or cellular)
You may not qualify if:
- Patients over 18 under legal protection
- Allergy to local anesthetics
- Existence of preoperative laryngeal dysphonia or paralysis
- Patient with a submerging goiter (lower edge of the thyroid not seen on the preoperative cervical ultrasound)
- Presence of uncontrolled infectious pathology
- Pregnant or breastfeeding woman or no contraception
- Lymph node dissection planned or patient at high risk of lymph node dissection (BETHESDA 5 and 6)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Caenlead
- Centre Francois Baclessecollaborator
Study Sites (1)
Caen University Hospital
Caen, 14000, France
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuel Babin
University Hospital, Caen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participant, surgeons and outcomes assessor are blind Only the anesthesiologist taking care of the patient knows the allocation group
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2020
First Posted
October 14, 2020
Study Start
November 28, 2019
Primary Completion
November 1, 2021
Study Completion
November 1, 2021
Last Updated
October 14, 2020
Record last verified: 2020-10